Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
36,72 € ↓ −1,56 (−4,08%)
2026-06-02
DELAT PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionHighPoint Advisor Group LLC
Latest Disclosed Ownership8,287 shares
Latest Disclosed Value $ 304,550
HighPoint Advisor Group LLC reports 0.13% increase in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 14, 2026 - HighPoint Advisor Group LLC filed a 13F-HR form disclosing ownership of 8,287 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $261,455 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 14, 2026 disclosing 8,276 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of 0.13% during the quarter. The current value of the position is $304,299 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NOVO NORDISK Common Stock 670100205 8,287 11 0.13 305 -27.79 0.0128
2026-05-14 2025-12-31 13F/A-2 NOVO NORDISK Common Stock 670100205 8,276 -11,638 -58.44 421 -61.90 0.0176
2026-02-04 2025-12-31 13F NOVO NORDISK A Common Stock 670100205 21,803 1,889 1,109 0.0515
2025-11-05 2025-09-30 13F NOVO NORDISK AS ADR Common Stock 670100205 19,914 503 2.59 1,105 -17.48 0.0526
2025-08-07 2025-06-30 13F NOVO NORDISK AS ADR Common Stock 670100205 19,411 -28 -0.14 1,340 5.77 0.0712
2025-05-05 2025-03-31 13F NOVO NORDISK AS ADR Common Stock 670100205 19,439 91 0.47 1,267 -21.85 0.0737
2025-02-12 2024-12-31 13F NOVO NORDISK AS ADR Common Stock 670100205 19,348 841 4.54 1,620 -21.78 0.0880
2024-11-04 2024-09-30 13F NOVO NORDISK AS ADR Common Stock 670100205 18,507 -266 -1.42 2,072 103,450.00 0.1208
2024-08-08 2024-06-30 13F NOVO NORDISK AS ADR Common Stock 670100205 18,773 297 1.61 2 0.00 0.1449
2024-05-14 2024-03-31 13F NOVO NORDISK AS ADR Common Stock 670100205 18,476 346 1.91 2 -99.91 0.1728
2024-03-26 2023-12-31 13F NOVO NORDISK AS ADR Common Stock 670100205 18,130 18,130 2,340 0.1676
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.